Description
Toremifene citrate is a selective estrogen receptor modulator (SERM) that is widely being used as endocrine therapy for estrogen receptor positive breast cancer. Toremifene citrate is known to increase bone mineral density in prostate cancer patients undergoing androgen deprivation therapy.
Toremifene citrate is a selective estrogen receptor modulator (SERM) that is widely being used as endocrine therapy for estrogen receptor positive breast cancer. Toremifene citrate is known to increase bone mineral density in prostate cancer patients undergoing androgen deprivation therapy.
B1049 | Toremifene citrate DataSheet
Alternate Name/Synonyms: (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine, Acapodene, Fareston, GTx 006, Z-Toremifene
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 89778-27-8
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₆H₂₈ClNO.C₆H₈O₇
Molecular Weight: 598.08
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (>10 mg/ml)
Handling: Protect from air and moisture
Country of Origin: USA
Tag Line: A selective estrogen receptor modulator (SERM)
MDL Number: MFCD01729016
PubChem CID: 3005572
SMILES: CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChi: InChI=1S/C26H28ClNO.C6H8O7/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-16H,17-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-;
InChi Key: IWEQQRMGNVVKQW-OQKDUQJOSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |